Chemical structure of molecule DS96432529 Daiichi Sankyo CDK8 kinase inhibitor

oral CDK8 kinase inhibitor

effective in ovariectomized rat model

CDK8 identified as MoA after screen

Bioorganic & Medicinal Chemistry Letters

Daiichi Sankyo Co. Ltd.

7.     The Daiichi Sankyo CDK8 kinase inhibitor, DS96432529, is intended to be a bone anabolic agent. The molecule shows preclinical efficacy and synergy with alendronate or parathyroid hormone. The discovery…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.